Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease
نویسندگان
چکیده
منابع مشابه
Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
BACKGROUND Diabetes mellitus, heart failure (HF), and chronic kidney disease are common comorbidities, but overall use and safety of antihyperglycemic medications (AHMs) among patients with these comorbidities are poorly understood. METHODS AND RESULTS Using Get With the Guidelines-Heart Failure and linked Medicare Part D data, we assessed AHM use within 90 days of hospital discharge among HF...
متن کاملHeart Failure, Diabetes Mellitus, and Chronic Kidney Disease: A Clinical Conundrum.
Type 2 diabetes mellitus and heart failure (HF) commonly coexist, with diabetes mellitus occurring in ≈25% of patients with chronic HF and ~40% in those hospitalized with acute HF. Importantly, the presence of diabetes mellitus in HF is associated with reduced survival and increased rates of hospitalization compared with HF patients without diabetes mellitus. Despite the common and dangerous co...
متن کاملDiabetes Mellitus and Heart Failure.
Epidemiologic and clinical data from the last 2 decades have shown that the prevalence of heart failure in diabetes is very high, and the prognosis for patients with heart failure is worse in those with diabetes than in those without diabetes. Experimental data suggest that various mechanisms contribute to the impairment in systolic and diastolic function in patients with diabetes, and there is...
متن کاملEffects of diabetes mellitus in patients with heart failure and chronic kidney disease: a propensity-matched study of multimorbidity in chronic heart failure.
BACKGROUND Chronic kidney disease (CKD) and diabetes mellitus (DM) are common comorbidities in heart failure (HF) and each is associated with poor outcomes. However, the effects of multimorbidity related to having both CKD and DM compared to CKD alone have not been well studied in a propensity-matched population of chronic HF patients. METHODS Of the 7788 ambulatory chronic HF patients in the...
متن کاملMineralocorticoid Receptor Antagonists in High‐Risk Heart Failure Patients With Diabetes Mellitus and/or Chronic Kidney Disease
T he steroidal mineralocorticoid receptor antagonists (MRAs) spironolactone and eplerenone have been shown in large-scale prospective double-blind trials to reduce cardiovascular mortality and hospitalizations for heart failure in patients with a reduced left ventricular ejection fraction (HFrEF). Their use in patients with midrange and preserved left ventricular function (HFpEF) remains contro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation: Heart Failure
سال: 2016
ISSN: 1941-3289,1941-3297
DOI: 10.1161/circheartfailure.116.003316